Biomarin Pharmaceutical Inc at Stifel Virtual Healthcare Conference Transcript
Great. Thanks very much, everybody. Happy to be here on this panel for the next 30 minutes with the BioMarin management team.
With me is Brian Mueller, who's the Executive Vice President and CFO; and also Hank Fuchs, who is the President of Worldwide R&D. I'm sure most people listening here know the team quite well.
I think we're just going to start and have Brian make some introductory remarks on the recent BioMarin quarter and a few pipelines updates and than we will get into Q&A.
So, Brian, thank you, again, and please take it away.
Hi, everybody. Thank you, Paul, really appreciate the opportunity to participate today. As you know, we recently shared our third quarter 2020 results where we provided a number of updates.
On the financials, we tightened our GAAP net income guidance and improved our non
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
